A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
Connie Franciosi, 80, was part of a trial that looked at using an mRNA vaccine and an immunotherapy drug to prevent the recurrence of melanoma.
Lynn Winkler
hide caption
toggle caption
Lynn Winkler
Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a…
The companies — and others — are testing similar approaches against lung, breast and pancreatic cancers.
CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win…
Promising trial results suggest cancer vaccines work and could be used to target other tumours.
Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy…
Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients.…
Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years
